We are live on ! Find out more
IBER

Ibere Pharmaceuticals
IBER

Delisted

IBER was delisted on the 1st of March, 2023.

Back to rankings

47 hedge funds and large institutions have $99.8M invested in Ibere Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

40% more capital invested

Capital invested by funds: $71.4M → $99.8M (+$28.3M)

24% more funds holding

Funds holding: 38 → 47 (+9)

Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
2
Closed
3
Calls
$114K
Puts
–
Net Calls
+$114K
Net Calls Change
+$25K

Top Buyers

Rank Fund Capital Flow
1
Brown Advisory
Brown Advisory
Maryland
+$26.5M
2
SCM
Shaolin Capital Management
Florida
+$3.27M
3
PC
Periscope Capital
Ontario, Canada
+$2.43M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.36M
5
GCL
Glazer Capital LLC
New York
+$1.72M

Top Sellers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
-$745K
2
AM
Ampfield Management
New York
-$432K
3
PCM
Prelude Capital Management
New York
-$35.3K
4
WAM
Wolverine Asset Management
Illinois
-$29K
5
Citadel Advisors
Citadel Advisors
Florida
-$49
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
1
Brown Advisory
Maryland
$11.7M +$26.5M +2,728,334 New
Citadel Advisors
2
Citadel Advisors
Florida
$7.55M -$49 -5 -0%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$6M – – –
Marshall Wace
4
Marshall Wace
United Kingdom
$5.17M +$791K +81,391 +18%
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$4.86M – – –
LA
6
Linden Advisors
New York
$4.37M – – –
Millennium Management
7
Millennium Management
New York
$4.33M +$1.06M +109,157 +32%
SC
8
Sculptor Capital
New York
$4.13M – – –
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$3.93M +$2.36M +242,637 +150%
SCC
10
Spring Creek Capital
Kansas
$3.88M – – –
VI
11
Vestcor Inc
New Brunswick, Canada
$3.88M – – –
SCM
12
Shaolin Capital Management
Florida
$3.27M +$3.27M +336,200 New
MCM
13
Moore Capital Management
New York
$2.92M – – –
RCM
14
Radcliffe Capital Management
Pennsylvania
$2.91M – – –
Nomura Holdings
15
Nomura Holdings
Japan
$2.75M – – –
PC
16
Periscope Capital
Ontario, Canada
$2.71M +$2.43M +249,600 +832%
CCA
17
Castle Creek Arbitrage
Colorado
$2.46M – – –
MP
18
Mangrove Partners
Connecticut
$1.94M – – –
PMAM
19
Picton Mahoney Asset Management
Ontario, Canada
$1.94M – – –
GCL
20
Glazer Capital LLC
New York
$1.81M +$1.72M +176,529 +1,667%
BCM
21
Basso Capital Management
Connecticut
$1.65M – – –
Wells Fargo
22
Wells Fargo
California
$1.62M – – –
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
$1.46M – – –
SSA
24
Schonfeld Strategic Advisors
New York
$1.31M – – –
CFIA
25
Cantor Fitzgerald Investment Advisors
New York
$1.09M +$1.09M +112,050 New
1
2

IBER Hedge Fund Activity: Q4 2021 in Review

47 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals (IBER) for Q4 2021, worth a combined $99.8M — up 40% from $71.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IBER positions and 3 closed out — a net gain of 11 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Brown Advisory, opening a new position worth an estimated $26.5M. The largest seller was AQR Arbitrage, exiting entirely with an estimated $745K sold.

  • 47 institutional investors held Ibere Pharmaceuticals (IBER) as of Q4 2021, up from 38 in Q3 2021.
  • Funds reported $99.8M of Ibere Pharmaceuticals stock for Q4 2021, up 40% quarter-over-quarter.
  • 14 funds opened new Ibere Pharmaceuticals positions in Q4 2021 and 3 closed out, a net change of +11 holders.
  • The largest Ibere Pharmaceuticals buyer in Q4 2021 was Brown Advisory, an estimated $26.5M added.
  • The largest Ibere Pharmaceuticals seller in Q4 2021 was AQR Arbitrage, an estimated $745K sold.

Based on aggregated 13F filings for Q4 2021.